NEW DELHI: Sending a strong message to China, the Quad at its first summit signaled its arrival on the geopolitical scene with PM Modi describing the cluster as a “force for global good” and an “important pillar of stability” in the Indo-Pacific. In its opening remarks, underlined the evolution of …
Read More »Explainer: Where are we in the Covid-19 vaccine race?
India became the fourth country to approve a coronavirus vaccine developed by the University of Oxford and AstraZeneca, authorizing the launch of the vaccine in the coming weeks in the country with the second highest number of infections. The following is what we know about the race to deliver vaccines …
Read More »Ten Covid-19 Vaccines Seen Mid-Year, Says Global Pharma Group Head
GENEVA: Ten Covid-19 vaccines could be available by the middle of next year if they get regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said on Friday. Vaccines from Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results …
Read More »The Indian vaccine co had an adverse event; experts seek more transparency | India News
MUMBAI: Hyderabad-based Bharat Biotech’s potential Covid-19 vaccine reported a serious adverse event during clinical trials in August, even as the Phase 3 stage of the study has now started. The adverse event occurred in a 35-year-old participant with no comorbidities, who was part of the Phase 1 trials in August, …
Read More »The Indian vaccine co had an adverse event; experts seek more transparency | India News
MUMBAI: Hyderabad-based Bharat Biotech’s potential Covid-19 vaccine reported a serious adverse event during clinical trials in August, even as the Phase 3 stage of the study has now started. The adverse event occurred in a 35-year-old participant with no comorbidities, who was part of the Phase 1 trials in August, …
Read More »J&J begins two-dose trial of its Covid-19 vaccine candidate in the UK
Johnson & Johnson launched a new late-stage trial in Britain on Monday to test a two-dose regimen of its experimental Covid-19 vaccine among thousands of volunteers, as the US drugmaker broadens its trials by geography and type. The British arm of the study aims to recruit 6,000 participants from a …
Read More »Johnson & Johnson Sees Covid-19 Vaccine Available Starting January
AstraZeneca’s vaccine candidate produced a strong immune response in older people, the Financial Times reported. Johnson & Johnson said the first batches of its injection could be available in January. Both companies are resuming trials that had been stopped for safety reasons. Spain announced a national curfew and Italy introduced …
Read More »Ailments in covid-19 trials raise questions about vaccine method
Johnson & Johnson said Monday night that it would stop its trial to investigate an illness, which it did not specify, in a study participant. Meanwhile, AstraZeneca Plc’s US trial of the vaccine it is developing with the University of Oxford has been halted by regulators for more than a …
Read More »Only Kerala and WB see a significant increase in active coronavirus cases in the last week
However, the upcoming festival season presents the highest risk to date of spreading the virus. Before Durga Puja, West Bengal is one of the few states where active cases continue to increase. Kerala, the only other major state with an increase in active cases, has already experienced a similar risk. …
Read More »Paris under curfew as Europe tightens virus restrictions Trump’s teenage son contracted virus, first lady reveals
In Spain, bars and restaurants will close throughout the northeast region of Catalonia for the next 15 days, as the country faces one of the highest infection rates in the European Union, with almost 900,000 cases and more than 33,000 deaths. The measures also went into effect in the Netherlands, …
Read More »